论文部分内容阅读
目的 :观察复方丹参早期治疗破入脑室脑出血是否引起再出血。方法 :选择 46例经头颅 CT证实的破入脑室脑出血患者 ,摒弃传统止血或中性治疗方法 ,于发病当天开始静脉点滴复方丹参 (CSM) 2 0 m L/ d,持续 14d～ 42 d,并于第 14天、2 8天、42天复查头颅 CT。结果 :无 1例发生再出血。结论 :早期静脉应用 CSM治疗破入脑室脑出血是安全的。其机制可能为 CSM能早期改善血肿周围及同侧和对侧远隔区域的脑组织局部脑血流量 (r CBF)下降 ,减轻继发蛛网膜下腔出血 (SAH)加重的脑缺血性损害 ,加快血肿吸收 ,预防脑水肿。
Objective: To observe whether the early treatment of compound Salvia miltiorrhiza can cause rebleeding after intracerebral hemorrhage. Methods: Forty-six patients with cerebral hemorrhage in ICU confirmed by skull CT were excluded from the traditional hemostatic or neutral treatment. The onset of onset of CSM was 20 m L / d for 14 days to 42 days, And in the first 14 days, 28 days, 42 days review skull CT. Results: None of the patients had rebleeding. CONCLUSIONS: Early intravenous CSM is safe for cerebral ventricular hemorrhage. The mechanism may be that CSM can early improve the reduction of regional cerebral blood flow (r CBF) around the hematoma and the ipsilateral and contralateral distant areas, and reduce the ischemic brain damage secondary to subarachnoid hemorrhage (SAH) , Accelerate the absorption of hematoma, prevent cerebral edema.